IC PHARMA DISTRIBUTION
- 0502.266.889
- BE0502266889
- Rue du Congrès 35, 1000 Bruxelles
- See the 136 companies at this address
- 4 January 2013
Profile
Official information from the CBE (FPS Economy).
IC PHARMA DISTRIBUTION is a Belgian company (Société à responsabilité limitée) whose registered office is established at 1000 Bruxelles. Its main activity falls under “Activités de portail de recherche sur le web” (NACE 63910).
- Legal form
- Société à responsabilité limitée
- Legal situation
- Situation normale
- Date of incorporation
- 4 January 2013
- Main activity (NACE)
- 63910Activités de portail de recherche sur le web
Secondary activities
7 additional NACE codes declared.
- 64999Autres activités des services financiers, nca
- 58190Autres activités d’édition, à l’exception de l’édition de logiciels
- 68110Achat et vente de biens propres
- 58190Autres activités d'édition
- 68100Activités des marchands de biens immobiliers
- 63120Portails Internet
- 64999Autres activités des services financiers
Anti-money-laundering (AML) compliance
Is this activity subject to the Belgian anti-money-laundering obligations? An indicative assessment based on the declared NACE code.
Given its declared activity (“Activités de portail de recherche sur le web”), IC PHARMA DISTRIBUTION belongs to a profession expressly covered by Belgian anti-money-laundering law.
Credit institutions, lenders, leasing and factoring companies, investment firms and fund managers are obliged entities.
- Identification and verification of the client's identity (KYC)
- Identification of the ultimate beneficial owners (UBO register)
- Assessment of money-laundering and terrorist-financing risks
- Ongoing diligence and monitoring of transactions
- Reporting suspicions to the CTIF
- Retention of the documents and appointment of an AMLCO
Legal basis: art. 5, §1, 4° and following of the Act of 18 September 2017.
General information based on the declared NACE activity code; it is not legal advice. Whether the obligations actually apply depends on the activity effectively carried out.
Your risk analysis on this company
AML Company ran IC PHARMA DISTRIBUTION through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2025 | -€346,912 | -€460 | €1,198gross margin | – |
| 2022 | -€377,851 | €344,696 | €370,023gross margin | – |
| 2020 | – | – | - | – |
| 2019 | – | – | - | – |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
This year's filing does not carry the item the calculation needs.
Result for the year / turnover
This year's filing does not carry the item the calculation needs.
Operating result / turnover
This year's filing does not carry the item the calculation needs.
Debts due after one year / balance sheet total
The filed denominator is zero or negative: the ratio would carry no meaning.
Result for the year / equity
Balance sheet structure
| Ratio | 2025 | 2022 | 2020 | Trend |
|---|---|---|---|---|
| Solvency | -777,2% 706,3% | -70,9% | - | |
| Liquidity | 0,11 x 0,47 | 0,58 x | - | |
| Net margin | - | - | - | - |
| Operating margin | - | - | - | - |
| Long-term debt | - | - | - | - |
| Return on equity | - | - | - | - |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (5)▾
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- SIEGE SOCIAL22 September 2021
- SIEGE SOCIAL16 August 2019
- DENOMINATION - SIEGE SOCIAL - OBJET - ASSEMBLEE GENERALE19 October 2017
- DEMISSIONS, NOMINATIONS4 October 2017
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the IC PHARMA DISTRIBUTION record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is IC PHARMA DISTRIBUTION subject to anti-money-laundering obligations in Belgium?
Did IC PHARMA DISTRIBUTION file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2026
- 20 July 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m81-fFiled accounts2026-00309650
- 2023
- 19 July 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m81-fFiled accounts2023-00249581
- 2021
- 27 October 2021Annual accounts filed·Financial year ended 31 December 2020 · Model m81-fFiled accounts2021-73200304
- 2020
- 20 October 2020Annual accounts filed·Financial year ended 31 December 2019 · Model m01-fFiled accounts2020-61900412
- 2019
- 15 October 2019Legal form · Articles of association · Appointments · ResignationsView the notice19339024
- 30 August 2019Annual accounts filed·Financial year ended 31 December 2018 · Model m01-fFiled accounts2019-62900055
- 2017
- 19 October 2017Registered office · Company name · Corporate purpose · General meetingView the notice17148133
- 2013
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
Sony Music Publishing Belgium
FEDERATION BELGE DU SECTEUR DE L'EAU - BELGISCHE FEDERATIE VOOR DE WATERSECTOR
AUTOVISTA BENELUX
european business angel network
UNIVERSAL MUSIC PUBLISHING
Chambre Belge des Traducteurs et Interprètes
Cercle d'Etudes Numismatiques
Belgische Dendrologische Vereniging - Société belge de Dendrologie
GEZINSBOND
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.